Bevacizumab plus irinotecan in recurrent malignant glioma. Our experience
García Cabezas, S., Serrano Blanch, R., Romeo Olmedo, J., Aranda Aguilar, E., Palacios Eito, A.Volume:
18
Language:
english
Journal:
Reports of Practical Oncology & Radiotherapy
DOI:
10.1016/j.rpor.2013.03.123
Date:
June, 2013
File:
PDF, 69 KB
english, 2013